Cencora Return on Investment 2010-2024 | COR
Current and historical return on investment (ROI) values for Cencora (COR) over the last 10 years.
| Cencora ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-06-30 | $2.53B | $5.23B | 48.81% |
| 2024-03-31 | $2.52B | $5.41B | 49.11% |
| 2023-12-31 | $2.53B | $5.25B | 49.83% |
| 2023-09-30 | $2.34B | $4.81B | 47.29% |
| 2023-06-30 | $2.32B | $5.08B | 47.10% |
| 2023-03-31 | $2.14B | $5.18B | 43.22% |
| 2022-12-31 | $2.36B | $4.73B | 46.76% |
| 2022-09-30 | $2.37B | $4.70B | 42.20% |
| 2022-06-30 | $2.47B | $5.16B | 40.06% |
| 2022-03-31 | $2.61B | $5.55B | 39.22% |
| 2021-12-31 | $2.45B | $7.01B | 36.20% |
| 2021-09-30 | $2.35B | $6.97B | 40.59% |
| 2021-06-30 | $-4.32B | $7.06B | -90.93% |
| 2021-03-31 | $-4.54B | $6.04B | -92.87% |
| 2020-12-31 | $-4.85B | $3.13B | -93.18% |
| 2020-09-30 | $-5.14B | $2.78B | -84.18% |
| 2020-06-30 | $1.16B | $7.59B | 15.99% |
| 2020-03-31 | $1.16B | $7.33B | 16.10% |
| 2019-12-31 | $0.90B | $6.71B | 12.43% |
| 2019-09-30 | $1.11B | $7.35B | 14.90% |
| 2019-06-30 | $1.09B | $7.45B | 14.45% |
| 2019-03-31 | $1.07B | $7.40B | 14.03% |
| 2018-12-31 | $1.50B | $7.68B | 19.32% |
| 2018-09-30 | $1.44B | $7.56B | 18.68% |
| 2018-06-30 | $1.15B | $7.85B | 15.81% |
| 2018-03-31 | $0.94B | $8.00B | 13.51% |
| 2017-12-31 | $1.08B | $7.49B | 16.57% |
| 2017-09-30 | $1.06B | $5.85B | 17.28% |
| 2017-06-30 | $1.42B | $6.34B | 23.02% |
| 2017-03-31 | $1.78B | $6.37B | 29.64% |
| 2016-12-31 | $2.10B | $5.99B | 34.77% |
| 2016-09-30 | $1.53B | $5.98B | 25.53% |
| 2016-06-30 | $1.84B | $5.67B | 33.09% |
| 2016-03-31 | $1.65B | $6.56B | 30.05% |
| 2015-12-31 | $0.33B | $5.69B | 6.28% |
| 2015-09-30 | $0.42B | $4.36B | 8.77% |
| 2015-06-30 | $0.09B | $5.32B | 1.93% |
| 2015-03-31 | $-0.13B | $5.86B | -2.98% |
| 2014-12-31 | $0.53B | $3.76B | 14.01% |
| 2014-09-30 | $0.78B | $3.95B | 20.69% |
| 2014-06-30 | $0.69B | $3.98B | 18.43% |
| 2014-03-31 | $0.71B | $3.54B | 19.30% |
| 2013-12-31 | $0.76B | $3.65B | 20.35% |
| 2013-09-30 | $0.90B | $3.72B | 23.94% |
| 2013-06-30 | $1.11B | $3.82B | 29.19% |
| 2013-03-31 | $1.29B | $3.74B | 32.88% |
| 2012-12-31 | $1.32B | $3.73B | 32.15% |
| 2012-09-30 | $1.30B | $3.85B | 30.50% |
| 2012-06-30 | $1.21B | $4.41B | 28.39% |
| 2012-03-31 | $1.21B | $4.44B | 27.98% |
| 2011-12-31 | $1.19B | $4.39B | 27.63% |
| 2011-09-30 | $1.19B | $3.84B | 27.76% |
| 2011-06-30 | $1.20B | $4.57B | 27.18% |
| 2011-03-31 | $1.16B | $4.48B | 26.80% |
| 2010-12-31 | $1.11B | $4.25B | 25.98% |
| 2010-09-30 | $1.09B | $4.30B | 25.83% |
| 2010-06-30 | $1.08B | $4.29B | 26.20% |
| 2010-03-31 | $1.01B | $4.19B | 25.00% |
| 2009-12-31 | $0.95B | $4.12B | 23.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $46.107B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |